TNRC6C

TNRC6C is a GW182-family effector of miRNA-mediated gene silencing that bridges Argonaute proteins to the mRNA decay and translational repression machinery (PMID:19383768). Its N-terminal GW-repeat region binds all four human Argonaute proteins (AGO1-AGO4), recruiting TNRC6C to miRNA-targeted transcripts, while its C-terminal silencing domain — which contains an RRM motif — independently drives translational repression and mRNA destabilization including deadenylation, even when uncoupled from AGO binding (PMID:19383768, PMID:19304925). Tethering of TNRC6C to a reporter mRNA dramatically inhibits protein synthesis through combined effects on mRNA level and translation (PMID:19304925). In vivo, TNRC6C carries a non-redundant role among GW182 paralogs in pulmonary microvascular maturation: its loss in mice causes failure of capillary apposition to surface epithelium during distal lung sacculation, neonatal respiratory failure, and downregulation of TGFβ1, TGFβR2, and VEGFR (PMID:28811219). In papillary thyroid cancer cells, TNRC6C overexpression suppresses proliferation, migration, and invasion and promotes apoptosis, accompanied by downregulation of a defined set of target transcripts (PMID:33564303).

1. 2009 High

   Established the modular architecture of TNRC6C as a silencing effector, resolving how it both engages the miRNA machinery and executes repression as separable activities.

   Evidence Tethering assays, reciprocal deletion mapping, mRNA stability and deadenylation reporter assays in human cells

   PMID:19304925 PMID:19383768

   Open questions at the time

   • Does not define which endogenous mRNAs are regulated
   • Stoichiometry and structural basis of AGO–GW-repeat binding not resolved
   • Decay machinery recruited by the C-terminal domain not identified
2. 2009 High

   Pinpointed the C-terminal RRM-containing domain as the key effector mediating translational repression, separating mRNA-level effects from translational inhibition.

   Evidence Domain deletion and mutagenesis of the TNRC6C C-terminus with reporter readouts

   PMID:19304925

   Open questions at the time

   • RNA-binding specificity of the RRM motif not characterized
   • Mechanistic link between the RRM and the translation apparatus unresolved
3. 2017 High

   Demonstrated a non-redundant physiological requirement for TNRC6C, showing GW182 paralogs are not functionally interchangeable in vivo.

   Evidence Conditional knockout mouse with lung histology, qRT-PCR, and cell population analysis

   PMID:28811219

   Open questions at the time

   • Whether the lung phenotype reflects loss of miRNA silencing activity specifically is not established
   • Direct miRNA/mRNA targets driving TGFβ and VEGFR downregulation not identified
   • Mechanism of paralog non-redundancy unknown
4. 2021 Medium

   Linked TNRC6C dosage to tumor-suppressive cellular behavior and nominated candidate downstream transcripts in a cancer context.

   Evidence Gain/loss-of-function in papillary thyroid cancer cell lines with RNA-sequencing and proliferation/migration/invasion/apoptosis assays

   PMID:33564303

   Open questions at the time

   • Single lab without mechanistic pathway placement
   • Whether identified targets are direct miRNA-pathway targets versus indirect is unclear
   • No in vivo tumor validation

• How TNRC6C-specific silencing activity connects to its non-redundant developmental role and its tumor-suppressive function remains unresolved.
• No endogenous miRNA target network mapped to a phenotype
• No structural model of the AGO–TNRC6C interaction
• Basis for paralog-specific function among GW182 proteins unknown